Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 26, 2018 - Business Wire
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today reported financial results for the fourth quarter and full year 2017.
"This last year included significant accomplishments for Kala, marked by a successful initial public offering, and the acceptance of a New Drug Application for INVELTYSTM (KPI-121 1%) for the treatment of infla...
Sign up today to gain access to 5 free articles a month from over 200 top subscription outlets.
Are you ready to take your business development to the next level with RelSci Professional?
Nurture your network with daily alerts that notify you when your relationships make news
Map your relationships to any target or prospect to identify a warm introduction
Access unlimited deep dossiers on over 8 million decision makers
Best of all, you can try out all these powerful business development tools absolutely free for 30 days!
Check out News Home to stay on top of the people and organizations you care most about.
